Literature DB >> 20171503

Radiation dose-volume effects in the stomach and small bowel.

Brian D Kavanagh1, Charlie C Pan, Laura A Dawson, Shiva K Das, X Allen Li, Randall K Ten Haken, Moyed Miften.   

Abstract

Published data suggest that the risk of moderately severe (>or=Grade 3) radiation-induced acute small-bowel toxicity can be predicted with a threshold model whereby for a given dose level, D, if the volume receiving that dose or greater (VD) exceeds a threshold quantity, the risk of toxicity escalates. Estimates of VD depend on the means of structure segmenting (e.g., V15 = 120 cc if individual bowel loops are outlined or V45 = 195 cc if entire peritoneal potential space of bowel is outlined). A similar predictive model of acute toxicity is not available for stomach. Late small-bowel/stomach toxicity is likely related to maximum dose and/or volume threshold parameters qualitatively similar to those related to acute toxicity risk. Concurrent chemotherapy has been associated with a higher risk of acute toxicity, and a history of abdominal surgery has been associated with a higher risk of late toxicity. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171503     DOI: 10.1016/j.ijrobp.2009.05.071

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  149 in total

Review 1.  Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan.

Authors:  Tejinder Kataria; Deepak Gupta; Trinanjan Basu; Shivani Gupta; Shikha Goyal; Susovan Banerjee; Ashu Abhishek; Shyam S Bisht; Kushal Narang
Journal:  Br J Radiol       Date:  2015-12-09       Impact factor: 3.039

Review 2.  Proton beam therapy for gastrointestinal cancers: past, present, and future.

Authors:  Shahed N Badiyan; Christopher L Hallemeier; Steven H Lin; Matthew D Hall; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2018-10

3.  RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma.

Authors:  G Z Gong; Y Yin; L G Xing; Y J Guo; T Liu; J Chen; J Lu; C Ma; T Sun; T Bai; G Zhang; R Wang
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

4.  Non-closure of peritoneum after abdominal hysterectomy for uterine carcinoma does not increase late intestinal radiation morbidity.

Authors:  Igor Sirák; Marian Kacerovský; Miroslav Hodek; Jiří Petera; Jiří Spaček; Linda Kašaová; Zdeněk Zoul; Milan Vošmik
Journal:  Rep Pract Oncol Radiother       Date:  2011-12-15

5.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

Review 6.  Personalized radiotherapy: concepts, biomarkers and trial design.

Authors:  A H Ree; K R Redalen
Journal:  Br J Radiol       Date:  2015-05-20       Impact factor: 3.039

7.  Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice.

Authors:  Magdalena Fundowicz; Marta Adamczyk; Anna Kołodziej-Dybaś
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-04

8.  Simultaneous integrated protection : A new concept for high-precision radiation therapy.

Authors:  Thomas B Brunner; Ursula Nestle; Sonja Adebahr; Eleni Gkika; Rolf Wiehle; Dimos Baltas; Anca-Ligia Grosu
Journal:  Strahlenther Onkol       Date:  2016-10-18       Impact factor: 3.621

9.  Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.

Authors:  Samhita Chakraborty; Monica M Morris; Todd W Bauer; Reid B Adams; Edward B Stelow; Gina Petroni; Hanna K Sanoff
Journal:  Gastrointest Cancer Res       Date:  2014-01

Review 10.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.